| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Longboard Pharmaceuticals, Inc.
13G/A
LBPH · 54300N103
|
0% |
2/11/2025
Event 12/31/2024
|
||||
| Zone II Healthcare Holdings, LLC | 0% | |||||
| Farallon Capital Partners, L.P. | 0% | |||||
| Farallon Capital Institutional Partners, L.P. | 0% | |||||
| Farallon Capital Institutional Partners II, L.P. | 0% | |||||
| Farallon Capital Institutional Partners III, L.P. | 0% | |||||
| Four Crossings Institutional Partners V, L.P. | 0% | |||||
| Farallon Capital Offshore Investors II, L.P. | 0% | |||||
| Farallon Capital (AM) Investors, L.P. | 0% | |||||
| Farallon Capital F5 Master I, L.P. | 0% | |||||
| Farallon Healthcare Partners Master, L.P. | 0% | |||||
| Farallon Capital Management, L.L.C. | 0% | |||||
| Farallon Partners, L.L.C. | 0% | |||||
| Farallon Institutional (GP) V, L.L.C | 0% | |||||
| Farallon F5 (GP), L.L.C. | 0% | |||||
| Farallon Healthcare Partners (GP), L.L.C. | 0% | |||||
| Dapice Joshua J. | 0% | |||||
| Dreyfuss, Philip D. | 0% | |||||
| Dunn Hannah E. | 0% | |||||
| Fried, Richard B | 0% | |||||
| Gehani, Varun N. | 0% | |||||
| Giauque, Nicolas | 0% | |||||
| Kim, David T. | 0% | |||||
| Linn, Michael G. | 0% | |||||
| Patel, Rajiv A. | 0% | |||||
| Roberts, Jr., Thomas G. | 0% | |||||
| Saito Edric C. | 0% | |||||
| Seybold, William | 0% | |||||
| Short Daniel S. | 0% | |||||
| Spokes, Andrew J. M. | 0% | |||||
| Warren, John R. | 0% | |||||
| Wehrly, Mark C. | 0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.